BLMS OTC
Bloomios, Inc.
1W: +0.0%
1M: +0.0%
3M: +200.0%
YTD: +200.0%
1Y: +200.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.000300000014
Volume450,000
Avg Volume3
Beta-0.46
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael Hill
Employees23
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2003-04-22
Websitebloomios.com
701 Anacapa Street
Santa Barbara, CA 93101
US
Santa Barbara, CA 93101
US
805 222 6330
About Bloomios, Inc.
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The companyâs product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rohrer Douglas S | 0 | — | 2022-11-22 | |
| Rohrer Douglas S | 550,000 | $1.69 | 2022-11-22 | |
| EMC2 Capital LLC | 0 | — | 2021-12-15 | |
| daprile bibi | 95 | — | 2021-07-09 | |
| elkayam aline hayuta | 95 | — | 2021-07-09 |